Review



mouse liver cancer cell lines h22  (iCell Bioscience Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    iCell Bioscience Inc mouse liver cancer cell lines h22
    CD3+CD8+ T cell-mediated cytotoxicity was measured by flow cytometry. A. For <t>H22</t> cells, the cytotoxicity in the LV-SMP30 group at the ratio of 10:1, 20:1 or 40:1. B. Statistical chart of target cell H22 specific lysis (%) in each group under different effector-target ratios. C. For Hep1-6 cells, the cytotoxicity in LV-SMP30 group at the ratio of 10:1, 20:1 or 40:1. D. Statistical chart of target cell Hep1-6 specific lysis (%) in each group under different effector-target ratios. These results indicate that LV-SMP30 transduced DCs enhances the CD3+CD8+ T cell-mediated specific cytotoxicity against H22 cells.
    Mouse Liver Cancer Cell Lines H22, supplied by iCell Bioscience Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse liver cancer cell lines h22/product/iCell Bioscience Inc
    Average 90 stars, based on 1 article reviews
    mouse liver cancer cell lines h22 - by Bioz Stars, 2026-06
    90/100 stars

    Images

    1) Product Images from "Dendritic cells modified by tumor associated antigen SMP30 have enhanced antitumor effect against mouse hepatocarcinoma cells in vitro and in vivo"

    Article Title: Dendritic cells modified by tumor associated antigen SMP30 have enhanced antitumor effect against mouse hepatocarcinoma cells in vitro and in vivo

    Journal: American Journal of Translational Research

    doi:

    CD3+CD8+ T cell-mediated cytotoxicity was measured by flow cytometry. A. For H22 cells, the cytotoxicity in the LV-SMP30 group at the ratio of 10:1, 20:1 or 40:1. B. Statistical chart of target cell H22 specific lysis (%) in each group under different effector-target ratios. C. For Hep1-6 cells, the cytotoxicity in LV-SMP30 group at the ratio of 10:1, 20:1 or 40:1. D. Statistical chart of target cell Hep1-6 specific lysis (%) in each group under different effector-target ratios. These results indicate that LV-SMP30 transduced DCs enhances the CD3+CD8+ T cell-mediated specific cytotoxicity against H22 cells.
    Figure Legend Snippet: CD3+CD8+ T cell-mediated cytotoxicity was measured by flow cytometry. A. For H22 cells, the cytotoxicity in the LV-SMP30 group at the ratio of 10:1, 20:1 or 40:1. B. Statistical chart of target cell H22 specific lysis (%) in each group under different effector-target ratios. C. For Hep1-6 cells, the cytotoxicity in LV-SMP30 group at the ratio of 10:1, 20:1 or 40:1. D. Statistical chart of target cell Hep1-6 specific lysis (%) in each group under different effector-target ratios. These results indicate that LV-SMP30 transduced DCs enhances the CD3+CD8+ T cell-mediated specific cytotoxicity against H22 cells.

    Techniques Used: Flow Cytometry, Lysis

    Construction of BALB/c nude mouse models of subcutaneous xenografts. A. BALB/c nude mice with equal-sized (~100 mm3) single H22 tumors were treated with CD3+CD8+ T cells. B. Recording chart of tumor growth process. C. Tumor volume on day 15: PBS group, Untreated group, LV group, Protein group, LV-SMP30 group (from left to right). D. Tumors harvested from mice on day 15: PBS group, Untreated group, LV group, Protein group, LV-SMP30 group (from left to right). E. Tumor growth curve. These results demonstrated that the tumor volume in the LV-SMP30 group was smaller than that of other control groups (P<0.05).
    Figure Legend Snippet: Construction of BALB/c nude mouse models of subcutaneous xenografts. A. BALB/c nude mice with equal-sized (~100 mm3) single H22 tumors were treated with CD3+CD8+ T cells. B. Recording chart of tumor growth process. C. Tumor volume on day 15: PBS group, Untreated group, LV group, Protein group, LV-SMP30 group (from left to right). D. Tumors harvested from mice on day 15: PBS group, Untreated group, LV group, Protein group, LV-SMP30 group (from left to right). E. Tumor growth curve. These results demonstrated that the tumor volume in the LV-SMP30 group was smaller than that of other control groups (P<0.05).

    Techniques Used: Control



    Similar Products

    mouse liver cancer cell line h22  (Keygen Biotech)
    90
    Keygen Biotech mouse liver cancer cell line h22
    Mouse Liver Cancer Cell Line H22, supplied by Keygen Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse liver cancer cell line h22/product/Keygen Biotech
    Average 90 stars, based on 1 article reviews
    mouse liver cancer cell line h22 - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    h22 mouse liver cancer cell line (cat. cl-0341)  (Procell Inc)
    90
    Procell Inc h22 mouse liver cancer cell line (cat. cl-0341)
    H22 Mouse Liver Cancer Cell Line (Cat. Cl 0341), supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/h22 mouse liver cancer cell line (cat. cl-0341)/product/Procell Inc
    Average 90 stars, based on 1 article reviews
    h22 mouse liver cancer cell line (cat. cl-0341) - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    mouse liver cancer cell lines h22  (iCell Bioscience Inc)
    90
    iCell Bioscience Inc mouse liver cancer cell lines h22
    CD3+CD8+ T cell-mediated cytotoxicity was measured by flow cytometry. A. For <t>H22</t> cells, the cytotoxicity in the LV-SMP30 group at the ratio of 10:1, 20:1 or 40:1. B. Statistical chart of target cell H22 specific lysis (%) in each group under different effector-target ratios. C. For Hep1-6 cells, the cytotoxicity in LV-SMP30 group at the ratio of 10:1, 20:1 or 40:1. D. Statistical chart of target cell Hep1-6 specific lysis (%) in each group under different effector-target ratios. These results indicate that LV-SMP30 transduced DCs enhances the CD3+CD8+ T cell-mediated specific cytotoxicity against H22 cells.
    Mouse Liver Cancer Cell Lines H22, supplied by iCell Bioscience Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse liver cancer cell lines h22/product/iCell Bioscience Inc
    Average 90 stars, based on 1 article reviews
    mouse liver cancer cell lines h22 - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    CD3+CD8+ T cell-mediated cytotoxicity was measured by flow cytometry. A. For H22 cells, the cytotoxicity in the LV-SMP30 group at the ratio of 10:1, 20:1 or 40:1. B. Statistical chart of target cell H22 specific lysis (%) in each group under different effector-target ratios. C. For Hep1-6 cells, the cytotoxicity in LV-SMP30 group at the ratio of 10:1, 20:1 or 40:1. D. Statistical chart of target cell Hep1-6 specific lysis (%) in each group under different effector-target ratios. These results indicate that LV-SMP30 transduced DCs enhances the CD3+CD8+ T cell-mediated specific cytotoxicity against H22 cells.

    Journal: American Journal of Translational Research

    Article Title: Dendritic cells modified by tumor associated antigen SMP30 have enhanced antitumor effect against mouse hepatocarcinoma cells in vitro and in vivo

    doi:

    Figure Lengend Snippet: CD3+CD8+ T cell-mediated cytotoxicity was measured by flow cytometry. A. For H22 cells, the cytotoxicity in the LV-SMP30 group at the ratio of 10:1, 20:1 or 40:1. B. Statistical chart of target cell H22 specific lysis (%) in each group under different effector-target ratios. C. For Hep1-6 cells, the cytotoxicity in LV-SMP30 group at the ratio of 10:1, 20:1 or 40:1. D. Statistical chart of target cell Hep1-6 specific lysis (%) in each group under different effector-target ratios. These results indicate that LV-SMP30 transduced DCs enhances the CD3+CD8+ T cell-mediated specific cytotoxicity against H22 cells.

    Article Snippet: Mouse liver cancer cell lines H22 and Hep1-6 were employed, purchased from iCell Bioscience Inc.

    Techniques: Flow Cytometry, Lysis

    Construction of BALB/c nude mouse models of subcutaneous xenografts. A. BALB/c nude mice with equal-sized (~100 mm3) single H22 tumors were treated with CD3+CD8+ T cells. B. Recording chart of tumor growth process. C. Tumor volume on day 15: PBS group, Untreated group, LV group, Protein group, LV-SMP30 group (from left to right). D. Tumors harvested from mice on day 15: PBS group, Untreated group, LV group, Protein group, LV-SMP30 group (from left to right). E. Tumor growth curve. These results demonstrated that the tumor volume in the LV-SMP30 group was smaller than that of other control groups (P<0.05).

    Journal: American Journal of Translational Research

    Article Title: Dendritic cells modified by tumor associated antigen SMP30 have enhanced antitumor effect against mouse hepatocarcinoma cells in vitro and in vivo

    doi:

    Figure Lengend Snippet: Construction of BALB/c nude mouse models of subcutaneous xenografts. A. BALB/c nude mice with equal-sized (~100 mm3) single H22 tumors were treated with CD3+CD8+ T cells. B. Recording chart of tumor growth process. C. Tumor volume on day 15: PBS group, Untreated group, LV group, Protein group, LV-SMP30 group (from left to right). D. Tumors harvested from mice on day 15: PBS group, Untreated group, LV group, Protein group, LV-SMP30 group (from left to right). E. Tumor growth curve. These results demonstrated that the tumor volume in the LV-SMP30 group was smaller than that of other control groups (P<0.05).

    Article Snippet: Mouse liver cancer cell lines H22 and Hep1-6 were employed, purchased from iCell Bioscience Inc.

    Techniques: Control